Pfizer was dismissed as a defendant in a sweeping antitrust lawsuit alleging that dozens of drugmakers and executives fixed generic drug prices. The development removes one legal overhang for Pfizer, but the broader case against the industry continues. The article provides no financial magnitudes or immediate business impact.
Pfizer was dismissed as a defendant in a sweeping antitrust lawsuit alleging that dozens of drugmakers and executives fixed generic drug prices. The development removes one legal overhang for Pfizer, but the broader case against the industry continues. The article provides no financial magnitudes or immediate business impact.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
neutral
Sentiment Score
0.05
Ticker Sentiment
